Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats

PLoS One. 2015 Dec 14;10(12):e0144355. doi: 10.1371/journal.pone.0144355. eCollection 2015.

Abstract

Background: We evaluated the side effects of bisphosphonate (BP) on tooth extraction socket healing in spontaneously diabetic Torii (SDT) rats, an established model of non-obese type 2 diabetes mellitus, to develop an animal model of BP-related osteonecrosis of the jaws (BRONJ).

Materials and methods: Male Sprague-Dawley (SD) rats and SDT rats were randomly assigned to the zoledronic acid (ZOL)-treated groups (SD/ZOL or SDT/ZOL) or to the control groups (SD/control or SDT/control). Rats in the SD/ZOL or SDT/ZOL groups received an intravenous bolus injection of ZOL (35 μg/kg) every 2 weeks. Each group consisted of 6 rats each. Twenty-one weeks after ZOL treatment began, the left maxillary molars were extracted. The rats were euthanized at 2, 4, or 8 weeks after tooth extraction, and the total maxillae were harvested for histological and histochemical studies.

Results: In the oral cavity, bone exposure persisted at the tooth extraction site in all rats of the SDT/ZOL group until 8 weeks after tooth extraction. In contrast, there was no bone exposure in SD/control or SDT/control groups, and only 1 of 6 rats in the SD/ZOL group showed bone exposure. Histologically, necrotic bone areas with empty lacunae, microbial colonies, and less invasion by inflammatory cells were observed. The number of tartrate-resistant acid phosphatase-positive osteoclasts was lower in the SDT/ZOL group than in the SD/control group. The mineral apposition rate was significantly lower in the SDT/ZOL group compared with the SD/control group.

Conclusions: This study demonstrated the development of BRONJ-like lesions in rats and suggested that low bone turnover with less inflammatory cell infiltration plays an important role in the development of BRONJ.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acid Phosphatase / genetics
  • Acid Phosphatase / metabolism
  • Animals
  • Bisphosphonate-Associated Osteonecrosis of the Jaw / complications
  • Bisphosphonate-Associated Osteonecrosis of the Jaw / metabolism
  • Bisphosphonate-Associated Osteonecrosis of the Jaw / pathology*
  • Bone Density
  • Bone Remodeling
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / pathology*
  • Diphosphonates / adverse effects*
  • Disease Models, Animal*
  • Gene Expression
  • Humans
  • Imidazoles / adverse effects*
  • Injections, Intravenous
  • Isoenzymes / genetics
  • Isoenzymes / metabolism
  • Male
  • Maxilla / metabolism
  • Maxilla / pathology*
  • Molar / metabolism
  • Molar / pathology*
  • Osteoclasts / metabolism
  • Osteoclasts / pathology*
  • Rats
  • Rats, Sprague-Dawley
  • Rats, Transgenic
  • Tartrate-Resistant Acid Phosphatase
  • Tooth Extraction
  • Zoledronic Acid

Substances

  • Diphosphonates
  • Imidazoles
  • Isoenzymes
  • Zoledronic Acid
  • Acid Phosphatase
  • Tartrate-Resistant Acid Phosphatase

Grants and funding

This study was supported by JSPS KAKENHI Grant Number 24593069, 15K11332 (to K.T.) and by Grant-in-Aid for Researchers, Hyogo College of Medicine, 2013 (to M.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.